presence of actinomycin. Appro-(1 Aug/ml, 1.9 X 104cpm/ml). Aliquots were removed priate concentrations of bacterial at times indicated, centrifuged at 2VC, and washed suspensions were plated on nutrient twice with ice-cold broth containing nonradioactive acbroth plates containing various tinomycin S3 (1 ,tg/ml). The washed cells were collected levels of actinomycin S3. The on a membrane filter, washed with 3 ml of cold actinoplates were incubated at 370C
mycin-containing broth, and the radioactivity retained overnight, and numbers of colonies on the filter was measured in a liquid-scintillation formed counted.
counter.
ments. ASi and AS12 require threonine, leucine, proline, histidine, and arginine for growth, as does their parent, AB1157. AS19 is a prototroph, as is B. AS27 has acquired a new growth requirement for isoleucine-valine; however, this requirement does not seem to be related to actinomycin sensitivity because AS27R, an actinomycin-resistant revertant from AS27, still has the requirement. The generation times in broth show that the mutants grow somewhat more slowly than do the parental strains. As judged by cross-streak tests, the mutants also retain their original sensitivity to phage. B and AS19 plate all T phages with almost equal efficiency. The character of actinomycin sensitivity in AS19 and AS27 is relatively unstable: they produce actinomycin-resistant revertants at frequencies of 10-3 to 10-5. Therefore, it is advisable to start each culture from a single colony and, before use, to check its sensitivity to lysozyme, as described below. ASI and AS12, on the other hand, are very stable; so far, no revertants have been isolated.
Uptake of actinomycin: To compare the abilities of actinomycin-resistant and sensitive cells to take up actinomycin, bacteria were incubated with H3-labeled actinomycin, washed in the cold, and the incorporated isotope measured. Figure   2 shows the time-course of incorporation by E. coli B and by AS19. The actinomycin-sensitive cells took up actinomycin to a final level of 40 m4g/109 cells, while little uptake occurred with the parent strain B. Most radioactivity retained in AS19 was recovered as a compound identified with actinomycin S3 on a radiochromatogram, suggesting that the actinomycin is taken up in AS19 as such, and not metabolized significantly. In addition, it was found that AS19R, an actinomycin-resistant revertant from AS19, also has diminished ability to incorporate Procedures and conditions were as described in Fig. 2 .
actinomycin (Table 1) . Essentially similar results were obtained with the actinomycin-sensitive mutant AS27 and its revertant AS27R. Thus, in these mutants sensitivity to actinomycin is correlated with ability to take up the antibiotic. However, there is a class of actinomycin-sensitive mutants which do not incorporate much actinomycin. These include AS1 and AS12 derived from strain AB1157, for which data are also shown in Table 1 . The sensitivity of these mutants does not seem to be associated with a change in permeability.
Inhibition of RNA synthesis by actinomycin: The effect of actinomycin on the incorporation of P32-orthophosphate into RNA and DNA in E. coli AS19 is shown in Table 2 . It is found that both RNA and DNA synthesis by the actinomycinsensitive mutant are strongly inhibited by relatively low concentrations of actinomycin. No such inhibition was observed with E. coli B. Similar results were obtained in other experiments in which the incorporation of p32 into nucleic acids in AB1157 and in AS12 were compared.
The effect of actinomycin on in vsitro RNA synthesis was studied by using crude extracts of E. coli B and AS19. Since the removal of DNA by deoxyribonuclease from the system reduced the rate to 5 per cent or less of that of the complete system, most of the activity measured appears to represent DNA-dependent RNA polymerase activity. The results are shown in Table 3 . In the cell-free system, E. coli RNA polymerase was effectively inhibited by actinomycin, as first found by Hurwitz et al.,' and the extent of inhibition with the two types of extracts were essentially the same. These results are compatible with the idea that ordinary E. coli has a permeability barrier which prevents access of actinomycin to its sites of action, and that the mutant is defective in that barrier.
The experiments described in the preceding section demonstrated that some actinomycin-sensitive mutants, such as AS1 and AS12, do not exhibit increased ability to take up actinomycin. The sensitivity of these mutants might be due to the existence of extraordinarily sensitive sites of action of the antibiotic. Therefore we investigated the effect of actinomycin on RNA polymerase, one of the possible sites. The results obtained for AB1157 and AS 12 are the same as those of B and AS19, and thus eliminate the possibility that the mutant contains a RNA polymerase system which is unusually sensitive to actinomycin. Sensitivity to lysozyme: Intact E. coli cells are resistant to the lytic action of lysozyme, but when treated with chloroform or EDTA they become susceptible. Presumably, these treatments cause an alteration in outer surface structures of the cell so that a glycopeptide layer can be attacked. If the increased sensitivity to actinomycin of the mutants is due to changes in their surface structure, the mutants might have become sensitive to lysozyme. To test this possibility, the sensitivity to lysozyme of actinomycin-sensitive cells was compared to that of the wild-type strain. Figure 3 demonstrates that AS19 and AS27 are, indeed, sensitive to lysozyme. An extensive decrease in turbidity occurred, due to cell lysis, when intact cells of the mutants were incubated with egg-white lysozvme. No decrease in turbidity was observed with the parental strain B.
The correlation of sensitivities to actinomycin and lysozyme was further demonstrated by the following experiments. Bacteria were incubated at 200C for 10 min in 0.05 M tris-chloride, pH 8, 20% sucrose. To prepare spheroplasts, 5 yg/ml of lysozyme with or without 0.25 mM EDTA was added prior to the incubation. ,X174 DNA (4 X 10'°phage equivalent DNA per ml) was added, and the mixture was incubated at 370C in a growth medium containing 20% sucrose. After 2 hr of incubation, the mixture was diluted with saline and plated on agar layer with a culture of E. coli C. bated with 100 Aug/ml of lysozyme and the surviving cells tested, 40 out of 42 survivors were resistant to actinomycin. ( 2) The treatment of AS19 and AS27 with lysozyme in a hypertonic medium produced spheroplasts. Ethylenediaminetetraacetate (EDTA), which is essential in making spheroplasts from ordinary E. coli cells, was not required. (3) AS19 and AS27 were lysed by phage-induced lysozyme. Phage T4, plated on these mutants, produced plaques with large halos formed by lysis of surrounding cells by phage lysozvme. No such halo was formed by T4 plated on B, or when a lysozyme-deficient mutant of T49 was plated on AS19 or AS27.
In spite of their high susceptibility to actinomycin, ASi and AS12 were resistant to lysozyme. Thus, also in this respect, these mutants derived from AB1157 are different from AS19 and AS27, derived from B.
Infection uith qX174 DNA: It has been shown that DNA isolated from 4X174
can infect E. coli spheroplasts but not normal cells. 8' 10, 11 This might be due to impermeability of the normal cell to DNA. Thus, it is of interest to see whether OX174 DNA can infect intact cells of actinomycin-sensitive mutants, which have enhanced permeability to actinomycin and possibly other compounds.
It was found that growing cultures of the actinomycin-sensitive mutants are not infectable with 4X174 DNA, but when the cells are incubated in a hypertonic medium they become susceptible. The results shown in Table 4 indicate that AS27 cells incubated in a tris-sucrose medium are as active as spheroplasts in producing infective centers from DNA. No significant increase in infective centers was observed with the parental strain B, or with C, the usual host of 4X174, incubated in the same medium. Thus, the actinomycin-sensitive mutants appear to be converted to a form susceptible to 4X174 DNA more easily than do the wild-type strains.
Discussion.-The actinomycin-sensitive mutants isolated thus far fall into two major categories. The first type, including AS19 and AS27 (isolated from strain B), takes up greater amounts of actinomycin than does the parent type; thus the increased sensitivity of these mutants to actinomycin may be due to loss of a permeability barrier. The second type, such as AS1 and AS12 (isolated from strain AB1157), does not exhibit an increased ability to take up the antibiotic, and the mechanism of this type of mutation is not evident.
Greater sensitivity to lysozyme is another notable feature of the first type of actinomycin-sensitive mutant. Lysozyme attacks glycopeptide in a rigid layer of the cell wall of both gram-positive and -negative bacteria. However, the intact cells of gram-negative bacteria are resistant to the action of lysozyme. The glycopeptide layer of gram-negative organisms such as E. coli is covered by layers of lipoprotein and lipopolysaccharide, so that removal of the outer layers by chloroform or phenol is necessary to digest the glycopeptide layer of these organisms by lysozyme.12' 13 The fact that sensitivities to actinomycin and to lysozyme are closely related in this type of mutant suggests that the mutants are defective in some part of the cell-wall structure, possibly in the lipoprotein or lipopolysaccharide layers, which serve as permeability barriers. It is to be recalled that the treatment of E. coli with EDTA results in the rapid release of components of cell-wall lipopolysaccharide,14 and that cells thus treated become sensitive to lysozyme as well as to actinomycin.15' 16 Preliminary observations with the electronmicroscope have revealed no major difference in surface structure of the mutant and the wildtype strains,"7 and more extensive studies are necessary to elucidate how the mutation alters permeability.
There are obvious advantages in the use of these mutants in various biological studies. Nucleic acid and protein syntheses in vivo can be readily controlled by actinomycin. As indicated by the experiment with 4X174 DNA, the mutant cells might take up various biologically active macromolecules more efficiently. It would be interesting to pursue the possibility of transformation of these cells.
Summary.-Two nitrosoguanidine-induced mutants of Escherichia coli, selected for their sensitivity to actinomycin, have been isolated and shown to be permeable to actinomycin and sensitive to lysozyme. Their RNA synthesis in vivo as well as in vitro are effectively inhibited by the antibiotic. Another type of actinomycinsensitive mutant was also isolated, which has low permeability to actinomycin and resistance to lysozyme.
